Intensity Therapeutics, Inc. (INTS) News
Follow Intensity Therapeutics, Inc. (INTS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Intensity Therapeutics Reports Quarterly Results
Intensity Therapeutics reported results for the quarter ended September 30. No financial figures are provided.
EQUITY | Nov 05, 2026, 04:14 PM UTC
M
Intensity Therapeutics Q3 Net Loss Widens on Higher R&D Costs
EQUITY | Nov 05, 2026, 01:03 PM UTC
M
Intensity Therapeutics Reports Wider Third-Quarter Net Loss
Intensity Therapeutics said higher research and development spending increased its third-quarter net loss year over year, citing costs for the INVINCIBLE-3 trial, a new INT230-6 manufacturing batch and salary-related exp
EQUITY | Nov 05, 2026, 12:47 PM UTC
L
INTS - Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
INTS - Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 08, 2026, 12:01 PM UTC
L
INTS INTS - Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
INTS INTS - Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
EARNINGS | Aug 04, 2026, 12:01 PM UTC